Advanced, Refractory Cancer

1 clinical trials · Condition

Record	Firm	Date
Patients With Refractory, Metastatic Cancer Harboring KIT Mutation or Amplification to Investigate the Clinical Efficacy and Safety of Imatinib Therapy (NCT02461849)	Samsung Medical Center	2014-04-04

Every clearance here is in the API, with alerts when new ones post.